Webinar :Join us on Jan 21, 22 and 23, 2021 at the ANYBODY CAN TRADE 360° LIVE virtual event. Register Now!

Granules India Q2 PAT seen up 4.4% YoY to Rs. 40 cr: HDFC Securities

Net Sales are expected to increase by 18.5 percent Y-o-Y (up 2.6 percent Q-o-Q) to Rs. 470 crore, according to HDFC Securities.

October 17, 2018 / 06:27 PM IST
Homoeopathic medicines.

Homoeopathic medicines.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

HDFC Securities has come out with its second quarter (July-September’ 18) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Granules India to report net profit at Rs. 40 crore up 4.4% year-on-year (down 18.7% quarter-on-quarter).


Net Sales are expected to increase by 18.5 percent Y-o-Y (up 2.6 percent Q-o-Q) to Rs. 470 crore, according to HDFC Securities.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 0.9 percent Y-o-Y (up 6.9 percent Q-o-Q) to Rs. 80 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol News

stay updated

Get Daily News on your Browser
Sections